261 related articles for article (PubMed ID: 28133789)
1. Diagnostic performance of procalcitonin, presepsin, and C-reactive protein in patients with hematological malignancies.
Ebihara Y; Kobayashi K; Ishida A; Maeda T; Takahashi N; Taji Y; Asou N; Ikebuchi K
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28133789
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in pediatric patients with febrile neutropenia.
Özdemir ZC; Düzenli-Kar Y; Canik A; Küskü-Kiraz Z; Özen H; Bör Ö
Turk J Pediatr; 2019; 61(3):359-367. PubMed ID: 31916713
[TBL] [Abstract][Full Text] [Related]
3. Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies.
Baraka A; Zakaria M
Int J Hematol; 2018 Aug; 108(2):184-191. PubMed ID: 29616457
[TBL] [Abstract][Full Text] [Related]
4. Usage of Plasma Presepsin, C-Reactive Protein, Procalcitonin and Proadrenomedullin to Predict Bacteremia in Febril Neutropenia of Pediatric Hematological Malignancy Patients.
Arıkan K; Karadag-Oncel E; Aytac S; Cetin M; Cengiz AB; Gümrük F; Kara A; Ceyhan M
Lab Med; 2021 Sep; 52(5):477-484. PubMed ID: 33851202
[TBL] [Abstract][Full Text] [Related]
5. Use of presepsin and procalcitonin for prediction of SeptiFast results in critically ill patients.
Mihajlovic D; Brkic S; Uvelin A; Draskovic B; Vrsajkov V
J Crit Care; 2017 Aug; 40():197-201. PubMed ID: 28432884
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders.
Koh H; Aimoto M; Katayama T; Hashiba M; Sato A; Kuno M; Makuuchi Y; Takakuwa T; Okamura H; Hirose A; Nakamae M; Hino M; Nakamae H
J Infect Chemother; 2016 Jul; 22(7):466-71. PubMed ID: 27184936
[TBL] [Abstract][Full Text] [Related]
7. Combination of sepsis biomarkers may indicate an invasive fungal infection in haematological patients.
Stoma I; Karpov I; Uss A; Krivenko S; Iskrov I; Milanovich N; Vlasenkova S; Lendina I; Belyavskaya K; Cherniak V
Biomarkers; 2019 Jun; 24(4):401-406. PubMed ID: 30907674
[No Abstract] [Full Text] [Related]
8. Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis.
Tsujimoto K; Hata A; Fujita M; Hatachi S; Yagita M
Int J Rheum Dis; 2018 Jul; 21(7):1406-1413. PubMed ID: 27291096
[TBL] [Abstract][Full Text] [Related]
9. The role of CRP, PCT, IL-6 and presepsin in early diagnosis of bacterial infectious complications in paediatric haemato-oncological patients.
Plesko M; Suvada J; Makohusova M; Waczulikova I; Behulova D; Vasilenkova A; Vargova M; Stecova A; Kaiserova E; Kolenova A
Neoplasma; 2016; 63(5):752-60. PubMed ID: 27468879
[TBL] [Abstract][Full Text] [Related]
10. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review.
Ruan L; Chen GY; Liu Z; Zhao Y; Xu GY; Li SF; Li CN; Chen LS; Tao Z
Crit Care; 2018 Nov; 22(1):316. PubMed ID: 30463590
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis.
Leli C; Ferranti M; Marrano U; Al Dhahab ZS; Bozza S; Cenci E; Mencacci A
J Med Microbiol; 2016 Aug; 65(8):713-719. PubMed ID: 27170331
[TBL] [Abstract][Full Text] [Related]
12. Presepsin as a predictor of septic shock in patients with urinary tract infection.
Sekine Y; Kotani K; Oka D; Nakayama H; Miyazawa Y; Syuto T; Arai S; Nomura M; Koike H; Matsui H; Shibata Y; Murakami M; Suzuki K
BMC Urol; 2021 Oct; 21(1):144. PubMed ID: 34641833
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Presepsin in Detection of Early-Onset Neonatal Sepsis.
Ozdemir AA; Elgormus Y
Am J Perinatol; 2017 May; 34(6):550-556. PubMed ID: 27825177
[No Abstract] [Full Text] [Related]
14. Presepsin versus other biomarkers to predict sepsis and septic shock in patients with infection defined by Sepsis-3 criteria: the PREDI study of diagnostic accuracy.
Contenti J; Occelli C; Lemoel F; Ferrari P; Levraut J
Emergencias; 2019 Oct; 31(5):311-317. PubMed ID: 31625302
[TBL] [Abstract][Full Text] [Related]
15. Early Differential Value of Plasma Presepsin on Infection of Trauma Patients.
Kang J; Gong P; Zhang XD; Wang WJ; Li CS
Shock; 2019 Sep; 52(3):362-369. PubMed ID: 30289851
[TBL] [Abstract][Full Text] [Related]
16. Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6.
García de Guadiana-Romualdo L; Español-Morales I; Cerezuela-Fuentes P; Consuegra-Sánchez L; Hernando-Holgado A; Esteban-Torrella P; Jiménez-Santos E; Viqueira-González M; de Béjar-Almira Á; Albaladejo-Otón MD
Support Care Cancer; 2015 Jul; 23(7):2175-82. PubMed ID: 25564222
[TBL] [Abstract][Full Text] [Related]
17. Pilot Study of Changes in Presepsin Concentrations Compared With Changes in Procalcitonin and C-Reactive Protein Concentrations After Cardiovascular Surgery.
Saito J; Hashiba E; Mikami A; Kudo T; Niwa H; Hirota K
J Cardiothorac Vasc Anesth; 2017 Aug; 31(4):1262-1267. PubMed ID: 28431809
[TBL] [Abstract][Full Text] [Related]
18. Validity of biomarkers in screening for neonatal sepsis - A single center -hospital based study.
Rashwan NI; Hassan MH; Mohey El-Deen ZM; Ahmed AE
Pediatr Neonatol; 2019 Apr; 60(2):149-155. PubMed ID: 29895470
[TBL] [Abstract][Full Text] [Related]
19. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens.
Stoma I; Karpov I; Uss A; Rummo O; Milanovich N; Iskrov I
Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):15-21. PubMed ID: 27793578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
